Could miRNA Signatures be Useful for Predicting Uterine Sarcoma and Carcinosarcoma Prognosis and Treatment?
Changes in microRNA (miRNA) expression may lead to cancer development and/or contribute to its progression; however, their role in uterine sarcomas is poorly understood. Uterine sarcomas (US) belong to a rare class of heterogeneous tumors, representing about 1% of all gynecologic neoplasms. This stu...
Main Authors: | Laura Gonzalez dos Anjos, Bruna Cristine de Almeida, Thais Gomes de Almeida, André Mourão Lavorato Rocha, Giovana De Nardo Maffazioli, Fernando Augusto Soares, Isabela Werneck da Cunha, Edmund Chada Baracat, Katia Candido Carvalho |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-09-01
|
Series: | Cancers |
Subjects: | |
Online Access: | http://www.mdpi.com/2072-6694/10/9/315 |
Similar Items
-
Oncomirs Expression Profiling in Uterine Leiomyosarcoma Cells
by: Bruna Cristine de Almeida, et al.
Published: (2017-12-01) -
The Dual Role of miR-186 in Cancers: Oncomir Battling With Tumor Suppressor miRNA
by: Ying Xiang, et al.
Published: (2020-03-01) -
MicroRNAs and Cancer
by: Maher, S.G., et al.
Published: (2020) -
The Dual Regulatory Role of MiR-181a in Breast Cancer
by: Chun Yang, et al.
Published: (2017-11-01) -
OMCD: OncomiR Cancer Database
by: Aaron L. Sarver, et al.
Published: (2018-12-01)